Presurgical therapy with axitinib for advanced renal cell carcinoma: a case report

BACKGROUND: Targeted therapy with tyrosine kinase inhibitors has been shown to reduce tumor volumes and prolong the survival of patients with metastatic renal cell carcinoma. Tyrosine kinase inhibitors, particularly sunitinib, have recently been used in neoadjuvant and presurgical settings. Axitinib...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:BMC Res Notes
Päätekijät: Koie, Takuya, Ohyama, Chikara, Okamoto, Akiko, Yamamoto, Hayato, Imai, Atsushi, Hatakeyama, Shingo, Yoneyama, Takahiro, Hashimoto, Yasuhiro
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: BioMed Central 2013
Aiheet:
Case Report
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC4222084/
https://ncbi.nlm.nih.gov/pubmed/24267160
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1756-0500-6-484
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia